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ABSTRACT 
The present study evaluates the removal capacity of two high rate algae ponds (HRAPs) to 
eliminate 12 pharmaceuticals (PhACs) and 26 of their corresponding main metabolites and 
transformation products. The efficiency of these ponds, operating with and without primary 
treatment, was compared in order to study their capacity under the best performance 
conditions (highest solar irradiance). Concentrations of all the target compounds were 
determined in both water and biomass samples. Removal rates ranged from moderate (40-
60%) to high (>60%) for most of them, with the exception of the psychiatric drugs 
carbamazepine, the β-blocking agent metoprolol and its metabolite, metoprolol acid. O-
desmethylvenlafaxine, despite its very low biodegradability in conventional wastewater 
treatment plants, was removed to certain extent (13-39%) Biomass concentrations suggested 
that bioadsorption/bioaccumulation to microalgae biomass was decisive regarding the 
elimination of some non-biodegradable compounds such as venlafaxine and its main 
metabolites. HRAP treatment with and without primary treatment did not yield significant 
differences in terms of PhACs removal efficiency. The implementation of HRAPs as 
secondary treatment is a viable alternative to CAS in terms of overall wastewater treatment 
(including organic micropollutants), with generally higher removal performances and 
implying a green, low-cost and more sustainable technology. 
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INTRODUCTION 
 
Our increasing dependence on pharmaceutical compounds (PhACs) has led to their 
widespread presence in all kind of environmental compartments, and at global level. PhACs 
are bioactive molecules that can remain as such even after being metabolized in the 
organism. They are generally highly resilient to biodegradation and so their removal during 
conventional wastewater treatment (based on activated sludge, (CAS)), is usually 
incomplete. Indeed, during the last decade, several studies have demonstrated that CAS 
treatment does not completely eliminate the vast majority of organic micropollutants, 
including PhACs (Archana et al., 2017; Bradley et al., 2017; García-Galán et al., 2011; Gros 
et al., 2007; Kostich et al., 2014; Li et al., 2019; Madikizela et al., 2017). However, CAS 
treatment does comply with the Council Directive 91/271/EEC requirements (European 
Union, 1991) regarding quality of wastewater effluents prior to their discharge in the 
environment (chemical oxygen demand (COD), biological oxygen demand (BOD), nitrogen, 
phosphorus and total suspended solids (TSS)). Highly prescribed/used compounds such as 
the anti-inflammatory diclofenac (DCF), the antiepileptic carbamazepine (CBZ) or the 
antibiotic sulfamethoxazole (SMX) are not completely removed by CAS WWTPs and they 
are regularly detected in environmental waters (García-Galán et al., 2011; Gros et al., 2010). 
Tertiary treatments such as advanced oxidation processes (AOPs) (i.e. UV, photo-fenton, 
ozonation), ultrafiltration or nanofiltration are then required to eliminate these pollutants 
more efficiently and obtain an effluent of much higher quality (Mamo et al., 2018; Taheran 
et al., 2016). These processes, however, are usually economically unfeasible and, in the case 
of AOPs, they put forward a new problem regarding the potential ecotoxicity of the different 
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transformation products (TPs) generated during the process (Fatta-Kassinos et al., 2011; 
García-Galán et al., 2016; Hübner et al., 2015). Nevertheless, the aforementioned low 
removal efficiency results in the regular entrance of these compounds onto the aquatic 
environment via discharge of wastewater effluents, constituting an ecotoxicological threat 
to non-target aquatic organisms directly or indirectly exposed to these substances 
(bioaccumulation and/or biomagnification) (Garcia-Galan et al., 2017; Langdon et al., 2010; 
Ruhí et al., 2016). Furthermore, and given the magnitude of the problem, scientific concern 
has also moved from the conventional monitoring studies on the presence of these PhACs 
and other pollutants in WWTP effluents or surface waters, to consider the presence of not 
only the parent drugs but also their metabolites and TPs and the ecotoxicological effects of 
the mixtures (Aristi et al., 2015; García-Galán et al., 2016).  
Taking all this into consideration, the search of alternative and more efficient 
treatments has become imperative. In particular, green, low-cost systems such as those based 
on microalgae have been investigated with great interest due to their high capability to 
remove nutrients, heavy metals and bacteria (García et al., 2006; Muñoz and Guieysse, 
2006). Open systems (usually high-rate algal ponds (HRAPs)) are the most commonly used, 
due to its versatility, easy operation and low maintenance costs. HRAPs are shallow raceway 
reactors in which microalgae and bacteria grow in symbiosis. Microalgae can grow in low 
quality water such as wastewater effluents, using up the nutrients they still contained, and 
releasing oxygen during photosynthesis. Concomitantly, the oxygen produced supports the 
respiration of heterotrophic bacteria, which are able to degrade organic matter. This 
symbiosis leads to the production of clean water as a by-product, and at the same time, to 
the growth and production of algal biomass that can be further stabilized, processed and 
converted to bioenergy (biodiesel and/or biogas) or biofertilizer (Benemann et al., 2013; 
Chisti, 2013; Thomas et al., 2016). Further advantages have been recently presented, such 
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as the production and intracellular accumulation, under specific growing conditions, of 
different added-value products such as glycogen, bioplastics or terpenoids, that can also be 
recovered from microalgae  (Arias et al., 2018; Khetkorn et al., 2017, 2016; Uggetti et al., 
2018). Taking all this into consideration, HRAP treatment could be considered as one of the 
most environmentally and economical favorable due to the reduced energy requirements and 
low operation and maintenance costs. Solar irradiation is therefore the main limiting factor 
regarding optimal growth rates and the biodegradative activity of microalgae (Nurdogan and 
Oswald, 1995).   
Despite the high efficiency of microalgae in removing nutrients and organic matter 
from wastewater, studies on their potential to eliminate organic micropollutants such as 
PhACs are still very scarce. Most importantly, metabolites or TPs of the original 
pharmaceuticals are very seldom addressed  (García-Galán et al., 2018; Jaén-Gil et al., 2018; 
Matamoros et al., 2015). In addition, data on biodegradation of PhACs by microalgae is 
usually based on lab-scale experiments carried out under sterile and controlled conditions, 
which are environmentally unrealistic (de Wilt et al., 2016; Ding et al., 2017). As happens 
with CAS treatments, HRAPs are not designed specifically to remove PhACs or other 
organic micropollutants, but their longer hydraulic residence times (HRTs) (usually several 
days vs hours of CAS), could favour the biodegradation of those contaminants with higher 
half-lives (and slow kinetics biodegradation). Other advantages to be highlighted are their 
high surface-area-to-volume ratio and subsequent higher sunlight exposures (enhancing the 
photodegradation pathways), the coexistence of autotrophic and heterotrophic 
microorganisms that improves the biomass productivity (and removal by adsorption to 
biomass), as well as biodegradation by different phototrophic, chemoorganotrophic and 
chemolithotrophic metabolic pathways (García et al., 2006; Nurdogan and Oswald, 1995). 
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Daily changes in pH, dissolved oxygen (DO) and redox conditions could also improve the 
removal mechanisms of PhACs in these systems (Norvill et al., 2017). 
The present study aims to evaluate the capacity of HRAPs to attenuate the 
concentration of 12 PhACs and 26 of their main metabolites and/or TPs, and to elucidate the 
removal mechanisms involved. Two HRAPs systems with different configurations (with and 
without primary treatment) were set up and compared during the beginning of summer, 
coinciding with the highest solar irradiation rates. 
2. MATERIALS AND METHODS 
2.1. HRAPs pilot plant description 
Samples were taken from a microalgae-based pilot plant installed outdoors at the 
laboratory of the GEMMA research group (Universitat Politècnica de Catalunya–
BarcelonaTech, Spain) and previously defined by Matamoros et al. (2015). Briefly, it 
consisted of two parallel treatment lines formed each by a primary settler, a HRAP and a 
settler or clarifier to separate the biomass produced from the treated effluent (see Figure 1).  
Each HRAP had a volume of 470 L (surface area of 1.54 m2, 0.3 m depth) and was equipped 
with a paddle wheel (working at 5 rpm approximately) in the middle of the pond to ensure 
the correct mixing of the liquor. Both systems were fed with domestic wastewater from the 
surrounding neighborhoods to the campus (residential areas), which was directly pumped 
from a municipal sewer to a homogenization tank (1.2 m3), which was continuously stirred 
to avoid solids sedimentation.  
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Figure 1. Diagram of the two HRAPs working in parallel and sampling points: 1. Raw wastewater/ HRAP-test influent; 2: 
HRAP-control influent (after primary settler); 3: HRAP-control mixed liquor; 4: HRAP-test mixed liquor; 5: HRAP-control 
effluent; 6: HRAP-test effluent. 
 
In order to evaluate the influence of primary treatment in the overall removal of the 
target PhACs, the primary settler of one of the lines was inoperative, so that the efficiency 
of both configurations could be compared.  The standard configuration of the HRAP 
(including the primary settler) was considered as the reference/control HRAP (HRAP-
control), whereas the second HRAP without that primary treatment was named HRAP-test 
(Figure 1). The systems were operating in continuous since November 2016 at a HRT of 4.5 
days. Further details on the operation of these systems are described elsewhere by Arashiro 
et al., (2019).  
 
2.2. Sampling strategy 
Sampling was carried out during two consecutive weeks in June 2017. Grab samples 
for the influent and effluent water of both ponds were taken daily from Monday to Friday 
from the 19th of June till the 30th of June 2017 (n=40 samples). For chemical characterization 
of the water, samples were taken in PVC bottles and directly analyzed in the laboratory. For 
PhACs analysis (environmental/real levels), samples were collected and immediately 
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filtered through 0.45 μm PVDF membrane filters (Millipore, USA) and frozen until analysis 
(amber glass bottles).  
Biomass samples were taken twice a week from each HRAP configuration (n=8 
samples) also in PVC samplers. They were immediately centrifuged at 4200 rpm for 10 min 
(Unicen 21, Ortoalresa, Spain), frozen at −80°C overnight in an ultra-freezer (Arctiko, 
Denmark) and finally freeze-dried for 24 h (−110 °C, 0.049 hPa) (Scanvac, Denmark). The 
biomass samples were then stored at -21°C until analysis. 
 
2.3. Chemicals and reagents 
High purity standards (>99%) of the pharmaceuticals acetaminophen (ACM), 
sulfadiazine (SDZ), sulfamethazine (SMZ), sulfamethoxazole (SMX), venlafaxine (VFX), 
diazepam (DZP), carbamazepine (CBZ), diclofenac (sodium salt) (DCF), fluoxetine (FXT), 
ibuprofen (IBF), metoprolol (MTP), metronidazole (MTZ), acetylsalicylic acid (ASA) and the 
metabolites norfluoxetine (desFXT) and 2-OH-carbamazepine (CBZ-OH) were purchased from 
Sigma-Aldrich (St. Louis. MO. USA). High purity standards for the metabolites ibuprofen 
carboxilyc acid (cbz-IBF), 1-OH- ibuprofen (1-IBF-OH), rac-2-OH-ibuprofen (2-IBF-OH), 4’-
OH-diclofenac (DCF-OH), diclofenac amide (adDCF), diclofenac acyl-B-D-glucuronide 
(gluDCF), acridone (ACRO), D,L-N-desmethyl venlafaxine (N-desVFX), D,L-O-desmethyl 
venlafaxine (O-desVFX), D,L-N,N-Didesmethyl venlafaxine, D,L-N,N-Didesmethyl-O-
desmethyl venlafaxine, N,O-Didesmethyl venlafaxine, N4-acetylsulfadiazine (acSDZ), N4-
acetylsulfamethazine (acSMZ), N4-acetylsulfamethoxazol (acSMX), 4-nitro-sulfamethoxazole 
(4-nitro-SMX),  desmethyldiazepam (desDZP), 3-OH-acetaminophen (ACM-OH), metoprolol 
acid (MTPA), α-OH-metoprolol (α-OH-HMTP), O-desmethylmetoprolol (O-DMTP), 
metronidazole-OH (MTZ-OH) and 10,11-epoxy carbamazepine (epoCBZ) were purchased 
from TRC (Toronto Research Chemicals Inc.. Ontario. Canada). Isotopically labelled 
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compounds, used as internal standards were purchased from Sigma-Aldrich (fluoxetine-d5, 
ibuprofen-d3), TRC (diclofenac-d4, 4’-OH-diclofenac-d4, sulfamethoxazole-d4, N,L-O-
desmethylvenlafaxine-d4 and acetaminophen-d4), Cerilliant (Texas, U.S.A.) (diazepam-d5) and 
from CDN isotopes (Quebec, Canada) (carbamazepine-d10 and venlafaxine-d6). Stock standard 
solutions for each of the compounds were prepared in MeOH at 1mg mL-1 and stored in the 
dark at −18 ◦C. Standard solutions of the mixtures of all compounds were made at appropriate 
concentrations and used to prepare the aqueous calibration curve and also to perform the 
recovery studies. Similarly, stock standard solutions for the internal standards were prepared. 
Aqueous standard solutions always contained <0.1% of MeOH.  
 
 2.4. Analytical methodologies 
2.4.1. Samples characterization 
Both influent and effluent water samples, together with the mixed liquor within the 
ponds (before the secondary settler) were analyzed on the following parameters: dissolved 
oxygen (DO) and temperature (EcoScan DO 6, ThermoFisher Scientific, USA) (daily); pH 
(Crison 506, Spain) and turbidity (Hanna HI 93703, USA), (three times per week); total 
suspended solids (TSS), volatile suspended solids (VSS), chlorophyll-a, according to 
Standard Methods (APHA-AWWA-WEF, 2012), NH4+-N according to Solórzano method 
(Solórzano, 1969) and NO2--N, NO3--N and PO43--P by ion chromatography (ICS-1000, 
Dionex Corporation, USA), twice a week). Ion chromatography was performed in isocratic 
mode with carbonate-based eluents at a temperature of 30°C and a flow of 1 mL min-1. Limits 
of detection (LOD) obtained were 0.9 mg/L of NO2--N, 1.12 mg/L of NO3--N, and 0.8 mg/L 
of PO43—P; alkalinity, total and soluble chemical oxygen demand (COD and sCOD) 
according to Standard Methods (APHA-AWWA-WEF, 2012), total  carbon (TC) and total 
nitrogen (TN) (multi N/C 2100S, Analytik Jena, Germany) (once a week). All the analyses 
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were done in triplicate and results were given as average values. Mixed liquor samples were 
regularly examined under an optic microscope (Motic, China) for qualitative evaluation of 
microalgae populations, employing taxonomic books and databases for their identification 
(Bourrelly, 1990; Palmer, 1962).  
Biomass productivity. 
 Average biomass productivity (gVSS m-²·d-1) was calculated based on 
the VSS concentration in the HRAPs mixed liquor samples and following 
(Arashiro et al., 2019),  using [1]: 
 𝐵𝑖𝑜𝑚𝑎𝑠𝑠 𝑝𝑟𝑜𝑑𝑢𝑐𝑡𝑖𝑣𝑖𝑡𝑦 =  
𝑉𝑆𝑆 (𝑄−𝑄𝐸+𝑄𝑃) 
𝐴 
 
[1] 
where 𝑉𝑆𝑆 is the volatile suspended solids concentration of the HRAP mixed liquor (g VSS L-1); 𝑄 
is the wastewater flow rate (L d-1); 𝑄𝐸 is the evaporation rate (L d-1); 𝑄𝑃 is the precipitation rate (L 
d-1); and 𝐴 is the surface area of the HRAP (1.54 m2). The evaporation rate was calculated using [2]: 
𝑄𝐸 =  𝐸𝑝  𝐴 [2] 
where 𝐸𝑝 is the potential evaporation (mm d-1), calculated  using [3] (Fisher and Pringle III, 2013). 
𝐸𝑝 = 𝑎  
𝑇𝑎
(𝑇𝑎 + 15)
(𝑅 + 50) [3] 
where 𝑎 is a dimensionless coefficient which varies depending on the sampling frequency (0.0133 
for daily samples); 𝑅 is the average solar radiation in a day (MJ m-2), and 𝑇𝑎 is the average air 
temperature (°C). Meteorological data were obtained from the net of local weather stations in 
Barcelona and metropolitan area (www.meteo.cat).  
 
2.4.2. UHPLC-MS/MS analysis of the target compounds 
Biomass samples 
Microalgae biomass samples were pre-treated and readied for UHPLC-MS/MS 
analysis following the method by Santos et al. (2019), which is briefly detailed in SI.  
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Water samples 
The different PhACs, metabolites and TPs were analyzed using a methodology 
adapted from García-Galán et al., (2016), and detailed in SI. Detailed data on method 
validation for water and biomass samples are given in SI. For both types of analysis, water 
and solid matrices, the performance of the methodology in terms on limits of detection and 
quantification of the method, recoveries of the biomass samples and matrix effects are given 
in SI. 
 
3. RESULTS AND DISCUSSION 
3.1. Overall performance of the HRAPs 
 Table 1 summarizes the operation conditions of both HRAPs, with no precipitation 
events and regular temperature of 20.7 ºC.  
Table 1. On-site parameters (average values) measured for both HRAPs during the sampling campaign 
  
Flow rate 
(L/d) 
HRT (d) DO (mg/L) 
Temperature 
(ºC) 
Turbidity 
(NTU) 
pH 
HRAP-C 111.7 ± 6 4,5 8.2 ± 1 20.8 ± 2.4 75.9 ± 63 8.3 ± 0.6 
HRAP-T 104.2 ± 6.2  4,2 7.1 ± 0.9 20.7  ± 2.4 110.8 ± 73.2 8.2 ± 0.1 
 
As expected, the absence of primary treatment led to higher TSS concentrations in HRAP-
test (29% higher in average) due to the greater inorganic solids concentrations entering this 
pond directly from the sewage system (Figure 2). VSS was also a 31% higher in HRAP-test. 
Regarding the physical-chemical quality parameters, both HRAP configurations presented 
similar nutrients and organic matter removal efficiencies (Table 2). The removal of NH4+-N 
was > 95% in both cases. Generally, NH4+-N is the preferential form of nitrogen uptake for 
most microalgae species, followed by NO3--N (Maestrini, 1982; Oliver and Ganf, 2002; 
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Ruiz-Marin et al., 2010). Furthermore, the high photosynthetic activity during summer 
increases the pH and favours NH4+-N volatilization, and also accelerates its partial 
nitrification to NO3-; indeed, despite the concentrations of NO3- and NO2- in the influent 
were very low, these were barely removed or not eliminated.  Nitrification of the influent N 
content (mostly NH4+) into NO3--N and NO2--N could explain those negative removals (de 
Godos et al., 2016; Van Den Hende et al., 2016). All in all, the TN removal efficiencies were 
positive but lower than those of NH4+-N (between 72% and 61% in HRAP-control and 
HRAP-test, respectively). Considering the maximum discharge values for TN registered in 
the Council Directive 91/271/EEC, we observe that the boundary limit of 15 mg L-1 is 
surpassed in both HRAPs. However, it should be noted that this value is given for systems 
treating wastewater for PE of 10 000-100 000, which is far bigger than the treatment capacity 
of the pilot HRAPs studied in this work. 
Average CODt and CODs removal efficiencies were very similar for both ponds, and 
are in accordance with previous studies under similar operational conditions (Young et al., 
2017; Sutherland et al., 2014). Effluent values comply with the Council Directive 
aforementioned. 
 
Table 2. Removal rates obtained for the different parameters evaluated in the wastewater samples during the sampling 
campaign 
  
Units 
HRAP-CONTROL HRAP-TEST 
Influent Effluent R% Influent Effluent R% 
CODt mg L-1 199 78 60.8 243 93 61.7 
CODs mg L-1 63 44 30.2 57 40 29.8 
NH4+-N mg L-1 24.9 1.2 95.2 24.1 0.6 97.5 
NO3--N mg L-1 1.1 11.4 - 1.0 8.5 - 
NO2--N mg L-1 4.2 3.4 19.0 2.4 3.0 - 
TN mg L-1 79.1 22.4 71.7 86.1 33.8 60.7 
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PO43--P mg L-1 3.4 2.2 35.3 4.1 7.5 - 
SO42--S mg L-1 44.4 53 - 39.9 51.2 - 
  
Regarding the biomass productivity, focusing in the two weeks of sampling (19th-
30th June), a higher productivity in HRAP-control than in HRAP-test was observed, 
especially during the first week (14.6 gVSS m-²·d-1 vs 5 gVSS m-²·d-1) (Figure 3).  Solar 
irradiance was very stable and similar during those days (see Figure S1 of SI). As mentioned, 
the higher TSS observed in HRAP-test blocked the light penetration in the pond, reducing 
the photosynthetic activity and the biomass growth. The highest productivity was achieved 
by the end of  the sampling campaing, with values of 21.7 gVSS m-²·d-1 in HRAP-control 
and 15.7 gVSS m-2·d-1 in HRAP-test. These results are similar to those obtained in previous 
works in HRAPs (Norvill et al., 2017; Sutherland et al., 2014).  
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Figure 2. Total suspended solids (TSS) and volatile suspended solids (VSS), dissolved oxygen and temperature measured 
in both HRAPs during the month of June. 
  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. Biomass productivity obtained in both HRAPs during the sampling campaign 
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3.2. Occurrence of PhACs in raw urban wastewater and primary treatment 
Nine compounds out of the 12 parent compounds and 15 out of the 26 metabolites 
and/or TPs were detected in influent wastewaters, with no significant differences between 
the concentrations observed before and after primary treatment (Table 3). The highest 
concentrations corresponded to IBF, a non-steroidal anti-inflammatory drug (NSAID), and 
one of its main human metabolites, 2-hydroxy-ibuprofen (2-OH-IBF), with levels in the 
range of 330-23811 ng L-1 for IBF and 15324-147755 ng L-1 for the metabolite. IBF is one 
of the most consumed anti-inflammatories in Europe, with estimated yearly consumptions 
in Spain of 250 tons (Ortiz de García et al., 2013). Another main metabolite, carboxy-
ibuprofen (cbx-IBF) was found in only a few samples, at a concentration ranging between 
16697 ng L-1 – 44211 ng L-1, one order of magnitude lower than levels detected in previous 
studies (Ferrando-Climent et al., 2012). This may be indicative of biodegradation events 
before reaching the HRAPs, as demonstrated recently by Jelic et al. for different PhACs in 
sewer pipes before reaching WWTPs (Jelic et al., 2015). Another NSAID, DCF, was 
detected in all the influent wastewater samples at concentrations ranging from 271 to 2126 
ng L-1. Its hydroxilated moieties, 4-hydroxy-diclofenac and 5-hydroxydiclofenac (4-OH-
DCF y 5-OH-DCF), were also frequently detected at significant levels (see Table 3). DCF is 
also one of the most widely prescribed anti-inflammatory and its incomplete removal during 
CAS treatment has led to its widespread presence in the environment  1 (Huerta et al., 2015; 
Oaks et al., 2004) . Acetylsalicylic acid (AcSAc), also a NSAID, was detected all days of 
sampling in the influent wastewater, but at very variable concentrations that ranged between 
166 ng L-1 and 5428 ng L-1. This variability was also observed in previous works (Gracia-
Lor et al., 2012; Gros et al., 2012). Acetaminophen (ACM) is also an analgesic frequently 
detected in WWTPs influents at levels similar to IBF (Gros et al., 2012; Mamo et al., 2018); 
in the present study, however, it was detected at a maximum concentration of  7800 ng L-1. 
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Regarding antibiotics, SMX and its acetylated metabolite, acSMX, were detected in all the 
influent samples (control and test), at concentrations ranging between 70 and 900 ng L-1 for 
SMX and much higher, 654 ng L-1 to 10188 ng L-1 ,for the metabolite, agreeing with the 
results of previous studies in which both compounds were detected in domestic wastewaters 
(García-Galán et al., 2016; Mamo et al., 2018; Rodriguez-Mozaz et al., 2015). This antibiotic 
is considered a ubiquitous pollutant in natural systems. Furthermore, among the family of 
sulfonamide antibiotics, SMX has been identified as the main responsible for the increase of 
sulfonamide resistance genes in WWTPs (Guo et al., 2017). 
The anti-depressant venlafaxine (VFX) and its two main metabolites, O-
desmethylvenlafaxine (O-desVFX) and N-desmethylvenlafaxine (N-desVFX), were present 
at average concentrations ranging between 664-702 ng L-1 for VFX, 738-817 ng L-1 for O-
desVFX and 108-115 ng L-1 for N-desVFX. The occurrence of three other minor VFX 
metabolites was also evaluated: N,N-didesmethylvenlafaxine (N,N-ddVFX) and N,O-
didesmethylvenlafaxine (N,O-ddVFX), which were detected at concentrations < 200 ng L-1; 
and N,N-Didesmethyl-O-desmethyl venlafaxine (N,N-dd-O-dVFX), which remained below 
LOD. VFX is widely used in the US and Europe, and its presence in wastewater has been 
widely demonstrateds ( García-Galán et al., 2016; Mamo et al., 2018). VFX undergoes 
metabolism in the liver, converting to its major metabolite, O-desVFX, an active compound 
which is itself also commercialized in Spain since 2012 (AEMPS, 2012). This metabolite is 
ubiquitous in wastewaters and surface waters and usually at concentrations two and three 
folds higher than those of VFX (García-Galán et al., 2016; Mamo et al., 2018). The 
antiepileptic carbamazepine (CBZ) and one of its main metabolites, 2-hydroxy-
carbamazepine (2-OH-CBZ), were present in all the influent samples but at concentrations 
< 33 ng L-1, values slightly lower than those found in previous studies (Dolar et al., 2012; 
García-Galán et al., 2016). 
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Metoprolol (MTP) was detected only in the influent samples of the HRAP-control, 
at concentrations ranging between 40 and 210 ng L-1, whereas one of its main metabolites, 
metoprolol acid (MTPA), was detected in all of them, at similar concentrations. These values 
are lower than those previously reported (Mamo et al., 2018; Rubirola et al., 2014) 
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Table 3. Concentrations of the different target compounds studied in the influent wastewater (n=10) of the ponds (ng L-1) and in the 
biomass (ng g-1 dw). FD: frequency of detection; (-): not detected; <LOQ: below the method limit of quantification 
  
HRAP-control 
 
  WATER BIOMASS 
  COMPOUND 
AVERAG
E 
 (ng L-1) 
Std 
Concentratio
n range  (ng L-
1) 
FD% 
AVERAG
E 
 (ng g-1) 
Std 
Concentratio
n range  (ng L-
1) 
FD% 
A
n
ti
b
io
ti
cs
 
Sulfamethoxazole 383.36 295.0 69.4-902.5 60 38.16 15.3 27.4-55.7 100 
N4 ̶ acetylsulfamethoxazole 2367.64 1827.4 653.8-10187.7 60 - - - - 
Nitrosulfamethoxazole - - - - 48.12 7.0 39.8-56.7 100 
Sulfamethazine 95.24 - - 10 - - - 100 
N4-Acetylsulfamethazine - - - - - - - 100 
Sulfadiazine - - - - - - - 100 
N4-Acetylsulfadiazine 1704.53 - - 10 - - - 100 
Metronidazole 369.83 676.9 23.5-1742.4 60 - - - 100 
OH-metronidazole - - - - 548.44 140.2 423.7-739.7 100 
P
sy
ch
ia
tr
ic
 d
ru
gs
 
Venlafaxine 625.84 230.8 382.4-1005.9 100 524.34 157.2 355.6-766 100 
N ̶ Desmethylvenlafaxine 108.33 88.4 38.8-292.3 100 379.80 79.2 297.3-461.7 100 
O ̶ Desmethylvenlafaxine 654.42 342.2 374.2-840.8 100 125.57 34.8 91.4-176.4 100 
N,N-
Didesmethylvenlafaxine 
67.51 33.3 44-91.1 20 112.78 18.3 93.5-130 75 
N,N-Didesmethy-O-
desmethyllvenlafaxine 
- - - - - - - - 
NO-desmethylvenlafaxine 95.96 44.4 49.3-113.1 60 100.68 22.0 76.6-127 100 
Fluoxetine - - - - 113.73 25.5 86.2-140.2 100 
Norfluoxetine 15.16 2.1 13,7-16,6 20 69.84 16.1 58.4-81.3 75 
Diazepam - - - - 6.13 0.4 5.8-6.4 50 
Desmethyldiazepam 2.85 2.5 - 30 - - - - 
Carbamazepine 20.95 10.8 9.6-42.4 100 24.94 8.1 18.7-36.5 100 
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Epoxy ̶  Carbamazepine - - - - 0.98 - 0.98 50 
2 ̶ OH-carbamazepine 32.09 20.9 11.1-75.7 100 2.86 - 2.86 25 
Acridone - - - - 52.03 19.4 29.1-76.1 100 
A
n
al
ge
si
cs
/ 
an
ti
in
fl
am
m
at
o
ri
es
 
Acetylsalicylic acid 845.44 462.7 272.6-4688.3 100 - - - <LOD 
Diclofenac 793.09 638.4 270.8-2117.8 100 88.58 99.5 6.9-216.1 75 
4-OH-Diclofenac 241.22 79.3 125.9-403.1 90 8.07 - 8.07 25 
5-OH-Diclofenac 856.52 456.4 380.75-1464.8 40 - - - - 
Diclofenac ̶ glucuronide - - - - - - - - 
Diclofenac amide - - - - - - - - 
Acetaminophen 1579.38 3045.5 156.4-7781.1 60 93.98 - 93.98 25 
Acetaminophen ̶ OH - - - - - - - - 
Ibuprofen 4731.18 7029.3 713.3-23811-4 100 467.69 176.9 283.4-671.7 75 
1-OH-ibuprofen 4819.75 3157.2 1813.1-9007.2 40 79.60 59.6 29.4-145.4 75 
2-OH-ibuprofen 49102.13 32790.1 15324.5-112839.7 100 152.21 85.4 78.9-242.2 75 
Carboxy-ibuprofen 22670.13 12069.5 16697-44211 50 38.45 31.4 10.6-74.6 100 
β
-b
lo
ck
in
g 
ag
en
ts
 Metoprolol 92.98 67.2 39.3-209.6 50 92.87 25.0 48.9-108.8 100 
Metoprolol ̶ acid 102.96 59.7 33.1-207.1 100 - - - - 
Alfa ̶ Metoprolol ̶ OH - - - - 35.44 7.2 28.4-44.9 100 
O ̶ Desmethyl ̶ Metoprolol - - - - - - - - 
 
 
 
 
 
 
  
HRAP-test 
 
  WATER BIOMASS 
  COMPOUND 
AVERAGE 
 (ng L-1) 
Std 
Concentration 
range  (ng L-1) 
FD% 
AVERAGE 
 (ng g-1) 
Std 
Concentration 
range  (ng L-1) 
FD% 
A
n
ti
b
io
ti
cs
 
Sulfamethoxazole 345.03 263.5 14.2-744.9 50 49.55 25.5 31.1-78.7 75 
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N4 ̶ 
acetylsulfamethoxazole 
2520.15 1565.9 901.2-4971.2 60 - - - - 
Nitrosulfamethoxazole - - - - - - - - 
Sulfamethazine 469.20 498.6 116.3-821.8 20 51.19 8.8 42.3-65.3 100 
N4-Acetylsulfamethazine - - - - - - - - 
Sulfadiazine - - - - - - - - 
N4-Acetylsulfadiazine 2733.00 - - 10 - - - - 
Metronidazole 429.31 677.1 39.5-1626.9 50 - - - - 
OH-metronidazole - - - - - - - - 
P
sy
ch
ia
tr
ic
 d
ru
gs
 
Venlafaxine 633.74 256.9 348.8-1038.9 100 329.03 75.5 232.3-439.3 100 
N ̶ Desmethylvenlafaxine 115.09 99.0 38.4-329.2 100 252.04 26.9 216.8-287.4 100 
O ̶ Desmethylvenlafaxine 577.37 308.4 134.7-1042.5 100 312.00 45.7 267.8-384.5 100 
N,N-
Didesmethylvenlafaxine 
60.13 37.5 37.9-103.5 30 124.38 17.0 100.2-146 100 
N,N-Didesmethy-O-
desmethyllvenlafaxine 
- - - - <LOQ - - <LOQ 
NO-desmethylvenlafaxine 87.81 67.0 30.6-195.1 60 132.94 14.0 120.8-149.2 100 
Fluoxetine - - -   187.26 53.1 119.1-240.8 75 
Norfluoxetine 14.41 4.1 11.5-17.3 20 102.13 51.8 44-169.4 75 
Diazepam - - - - 9.03 1.0 7.9-10.4 100 
Desmethyldiazepam 2.63 0.9 2-3.3 20 - - - - 
Carbamazepine 21.58 11.9 9.7-46.2 100 14.96 2.8 10.9-18.1 100 
Epoxy ̶  Carbamazepine 5.34 0.6 4.9-5.7 20 7.69 1.7 6.5-8.9 50 
2 ̶ Hydroxycarbamazepine 29.24 17.2 10.9-68.4 100 6.60 2.2 3.6-8.8 100 
Acridone - - -   77.76 15.6 61.1-97.5 100 
A
n
al
ge
si
cs
/ 
an
ti
in
fl
am
m
at
o
ri
es
 
Acetylsalicylic acid 1307.36 1580.3 165.8-5428.1 100 - - <LOD - 
Diclofenac 784.87 560.7 288.1-2126.5 100 267.98 159.6 283.1-424.4 75 
4-OH-Diclofenac 217.26 104.3 97.3-414.1 100 9.79 2.4 7.2-12.1 50 
5-OH-Diclofenac 739.78 505.6 387.9-1484.9 40 - - - - 
Diclofenac ̶ glucuronide - - - - 1.41 - 1.41 25 
Diclofenac-amide - - - - - - - - 
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Acetaminophen 2035.94 3164.1 351.2-6779.1 40 136.13 131.0 35.7-284.3 50 
Acetaminophen ̶ OH - - - - 842.71 246.2 659.3-1269.5 100 
Ibuprofen 4288.07 6478.2 329.7-21474-1 100 83.98 52.8 36.7-171.8 100 
1-OH-ibuprofen 4707.97 3573.3 990.9-8117.8 30 148.63 127.8 37.6-365.3 100 
2-OH-ibuprofen 53145.73 40840.1 15889.4-147755.1 100 36.97 26.9 5.7-66.6 75 
Carboxy-ibuprofen 25215.22 10481.5 18154-40779 40 137.65 145.3 15.1-341.6 100 
β
-b
lo
ck
in
g 
ag
en
ts
 Metoprolol 81.71 - - 10 - - - - 
Metoprolol ̶ acid 118.76 71.9 16.6-223.4 100 69.04 22.3 51.4-107.5 100 
Alfa ̶ Metoprolol ̶ OH - - - - - - - - 
O ̶ Desmethyl ̶ Metoprolol - - - - - - - - 
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3.3. Removal of target PhACs 
Removal of anthropogenic contaminants in biological treatment systems comprise 
mainly biodegradation, bioadsorption and/or bioaccumulation and, in the case of HRAPs, 
photodegradation should not be neglected either. Considering the operational HRT of 4 d in 
both ponds, removal rates were calculated using the average influent concentration of 4 
consecutive days, and the effluent of the fifth day, as shown in [4]: 
𝑅𝑒𝑚𝑜𝑣𝑎𝑙 (%) =  100 𝑥 
(?̅?𝑖𝑛𝑓 − 𝐶𝑒𝑓𝑓) 
?̅?𝑖𝑛𝑓 
 [4] 
where Cinf is the average influent concentration of four consecutive days and Ceff the 
effluent concentration of the fifth day. A total of 6 removal values (for each HRAP) were 
estimated during the two weeks of sampling.  In order to get representative results, removals 
were only estimated for those compounds detected in the influent and effluent wastewater at 
least 4 days out of the 10 days of sampling.  A comparison between the removal efficiencies 
of HRAPs with and without primary treatment was also carried out, performing a t-student 
analytical test (values are given in SI).  
The removals in both HRAP systems are depicted in Figure 4. The elimination of the 
antibiotic SMX and its metabolite AcSMX were higher in HRAP-test (average values of 
85.3% and 89.2%, respectively) than in HRAP-control (50.5% and 82.4%), although in both 
cases, differences were not significant (p>0.05). Due to the higher TSS concentration in the 
pond without primary treatment, it could be assumed that direct photodegradation did not 
play a relevant role in the elimination of this antibiotic. However, microalgae can become 
naturally occurring photosensitizers, generating oxidant species such as hydroxyl radicals 
and singlet oxygen leading to indirect photolysis of different PhACs (Fatta-Kassinos et al., 
2011; Ge et al., 2009). Indeed, Bai and Acharya (2017) observed that the organic matter 
associated with the microalgal cells could induce indirect photolysis of SMX. Likewise, 
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SMX is highly water soluble and, at the pond’s pH, it is in its anionic form (more stable), 
which could justify a limited bioadsorption/bioaccumulation to algal cells due to electrostatic 
repulsion (algal cells are also negatively charged). Concentrations found in the biomass are 
low, with barely 30 ng g-1 and 50 ng g-1 in HRAP-control and HRAP-test biomass, 
respectively. These results suggest that biodegradation/bioassimilation should be considered 
as the main elimination route of this antibiotic during microalgae treatment, neglecting the 
possibility of sorption to biomass. Indeed, previous studies demonstrated the low efficiency 
of green algae (Nannochloris sp.) to remove SMX (30%) by bioadsorption under lab-
conditions (Bai and Acharya, 2016). Its removal during CAS treatment is quite variable, 
usually ranging between 50% and 70%, showing also low  Kd values on sewage sludge 
(García-Galán et al., 2011; Trinh et al., 2016). Advanced treatment techniques such as 
membrane bioreactors (MBRs) do not seem to improve these efficiencies, yielding similar 
eliminations (García Galán et al., 2012; Mamo et al., 2018). Only the combined use of MBRs 
followed by reverse osmosis or nanofiltration has proved to be more efficient, achieving 
removals near 100% (Dolar et al., 2012; Mamo et al., 2018). On the contrary, ozonation, 
chlorination or indirect photodegradation are highly effective in removing this antibiotic, but 
pose the threat of the potential toxicity of the TPs generated (Baran et al., 2006; Zessel et al., 
2014).   
The elimination of the antibiotic metronidazole (MTZ) was high in both HRAPs 
(>89% in HRAP-control and >91% in HRAP-test), and no significant difference was 
observed between both ponds. These results are in accordance with previous results in 
HRAPs with a pretreatment configuration (Díaz-Garduño et al., 2018). However, MTZ was 
not detected in any biomass sample, being sorption discarded as elimination mechanism. 
The removal of MTZ during CAS treatment is generally incomplete, with R% usually < 30% 
as demonstrated in different studies (Dolar et al., 2012; Gros et al., 2012; Jelic et al., 2011). 
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This negligible elimination agrees with its resilience to biodegradation observed in 
standardized close bottle test (OECD 301D) (Alexy et al., 2004). On the contrary, the 
photosensitivity of this antibiotic has been previously demonstrated (Tong et al., 2011), and 
it is considered to be fully mineralized once discharged on natural waters. Therefore, 
photodegradation seems to be the most likely removal mechanism in the HRAPs (Figure 5). 
Regarding β-blocking agents, the removal of MTP in HRAP-control was very low 
and highly variable, ranging from no elimination to a maximum of 36%. MTPA was not 
fully removed in any of the ponds and it showed also a high variability, with values in HRAP-
control ranging from no removal to 100%. In HRAP-test, however, only one value out of six 
was positive (32.3%) for the metabolite. Higher concentrations of MTPA in the treatment 
effluent cannot be attributed to MTP biodegradation/biotransformation, as it was barely 
removed and/or not present in the influent (in the case of HRAP-test). Furthermore, MTPA 
was detected in all the biomass samples, at concentrations between 30-65 ng g-1.  Previous 
studies carried out in WWTPs justified these higher concentrations of MTPA in effluent 
wastewaters to primary degradation of atenolol and not only MTP, as MTPA is a common 
biodegradation product of both β-blocking agents (Mamo et al., 2018; Radjenović et al., 
2008; Rubirola et al., 2014). Despite it was out of the scope of this study, atenolol is more 
frequently detected than MTP in urban wastewaters (Dolar et al., 2012; Gros et al., 2013) 
and the presence of MTPA in effluent wastewaters could be attributed to the background 
presence and degradation of atenolol during microalgae treatment (Díaz-Garduño et al., 
2018; Villar-Navarro et al., 2018). Up to date, only fungal treatment has seemed effective in 
the removal of MTPA, but under lab-scale conditions (Jaén-Gil et al., 2019). 
VFX showed positive but limited overall removals in both ponds, with a better 
elimination in HRAP-control (49%-67%) than in HRAP-test (17%-53%), although 
differences were not significant in average (p>0.05). Its main metabolites, O-desVFX and 
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N-desVFX, also showed low removal rates (13-39% and 27-42%, respectively), but a much 
higher variability. In contrast, previous studies on the elimination of these compounds during 
CAS or MBR treatments demonstrated their limited sorption to sludge (low Kd) and their 
resilience to biodegradation (García-Galán et al., 2016; Mamo et al., 2018). 
Photodegradation could be considered as the main elimination route for VFX in these 
systems, and of higher relevance in HRAP-control than in HRAP-test, due to the lower TSS 
and higher light penetration. The high photodegradability in natural waters of VFX and O-
desVFX has already been demonstrated by Rúa-Gómez and Püttmann (2013), who even 
concluded that once discharged in natural waters these compounds would not pose an 
environmental risk due to this removal pathway, despite its low biodegradability.  On the 
other hand, the levels found in the biomass for these three compounds were the highest of 
all the compounds evaluated (see Figure 5). As explained by  Santos et al., (2019), and 
contrary to SMX, VFX is positively charged at pH 8.1, and a strong sorption may occur due 
to electrostatic forces with the biomass (negatively charged). Regarding the two minor 
metabolites of VFX detected in the systems, N,N-ddVFX was  almost completely removed 
in both HRAP-control and HRAP-test (average R% of 85% and 88.6%, respectively) 
whereas N,O-ddVFX was only removed in HRAP-control (65%) and remained in HRAP-
test. This metabolite is probably a secondary product of the degradation of the main 
metabolites of VFX, leading to its presence in effluent wastewaters. The removal of N,O-
ddVFX was significantly different between both ponds (p<0.05).   
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Figure 4. Removals (R%) obtained for the different families of pharmaceuticals in HRAP with primary treatment 
(white boxes) and HRAP without primary treatment (grey boxes). ▲: average value (the horizontal line is the median 
value). C and T at the end of the name of the compounds refer to HRAP-control and HRAP-test, respectively. 
 
Regarding CBZ, no removal was observed in either of the ponds. Different studies have 
reported low removals of CBZ in HRAPs with a pretreatment configuration, ranging from 
9% to 23% with HRT of 6 d (Díaz-Garduño et al., 2018; Villar-Navarro et al., 2018). 
Matamoros et al., (2015) obtained removals of 46% (4 d of HRT) and 62% (8 d HRT) during 
the warm season, highlighting that even under the best conditions for HRAP efficiency 
(summer campaigns), CBZ seems to remain unaffected. CBZ elimination in CAS treatments 
is also negligible, as demonstrated in several studies (Hai et al., 2018). It should be 
considered that gluruconide moieties of CBZ have never been included in monitoring studies 
due to the lack of commercial standards. Deconjugation of these metabolites into the original 
parent compound could explain the regular presence of CBZ in effluents of the different 
wastewater treatments systems, including HRAPs. Indeed, Vieno et al., (2007) demonstrated 
the cleavage of CBZ gluruconide forms during CAS wastewater treatment, and their 
decrease in concentration. On the contrary, the removal of its hydroxylated metabolite was 
positive in both cases, with values >50% in HRAP-control and between 38-54% in HRAP-
test.  On the other hand, CBZ was detected in all the biomass samples, at slightly higher 
concentrations in HRAP-control (19-36.5 ng g-1) than in HRAP-test (13-18 ng g-1). 
Acridone, a photodegradation byproduct of CBZ, was also present in all the biomass samples 
despite not being detected in the influent wastewater to the ponds, and the negligible removal 
of CBZ. In recent studies carried out under lab-controlled conditions with green algae 
Chlorella sp. and Scenedesmus sp., a 20% removal of CBZ was achieved (Matamoros et al., 
2016) , and Xiong et al., (2016) obtained CBZ removals up to 37% by freshwater microalgae 
Chlamydomonas mexicana and Scenedesmus obliquus. In this last study, the authors 
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concluded that bioadsorption and bioaccumulation were negligible, being biodegradation the 
main elimination mechanism. De Wilt et al., (2016) obtained eliminations between 10% and 
30% in different lab-scale batch experiments with green microalgae Chlorella sorokiniana, 
reaching similar conclusions. Low removals of CBZ are also frequently reported after CAS 
treatment, and it is considered as a non-degradable, recalcitrant compound (Hai et al., 2018).   
All in all, the results obtained in this study are consistent with these previous studies and 
again demonstrate the stability of this compound towards photodegradation and aerobic 
biodegradation (both in CAS and microalgae treatments). CBZ represents a real challenge 
in achieving an efficient elimination strategy in real scenarios, and the role of the metabolites 
in the elimination rate of the parent compound should be considered.  
ACM was completely removed in both ponds and not detected in biomass. On the 
contrary, its main metabolite 3-OH-acetaminophen (ACM-OH) was only detected in the 
biomass of both ponds, reaching concentrations >800 ng g-1 in the HRAP-test. Previous 
studies also demonstrated a rapid elimination of ACM in HRAPs with primary treatment 
(Matamoros et al., 2015; Villar-Navarro et al., 2018) and also by Chlorella sorokiniana in 
different batch experiments at lab scale (de Wilt et al., 2016). ACM is a readily 
biodegradable compound which is fully eliminated after CAS wastewater treatments. 
Furthermore, it has been concluded that it is photodegradable in surface waters, so that both 
mechanisms should be pointed out in HRAPs processes. Regarding AcSAc, it showed a very 
high elimination variability in HRAP-control, with much higher concentrations in the 
effluents of the pond. This compound was not eliminated either in previous studies with 
HRAPs (Díaz-Garduño et al., 2018). The presence of AcSAc in biomass was also negligible. 
DCF showed an incomplete removal in both ponds, averaging 54.8% in HRAP-
control and 51.3% in HRAP-test. It was detected in biomass samples at quite high 
concentrations too, especially in HRAP-test, so that bioadsorption/bioaccumulation could 
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account partly for its elimination.  However, de Wilt et al., (2016) obtained similar removals 
for DCF (40-60%) in batch reactors using Chlorella sorokiniana and attributed its 
elimination to phototransformation, as it was removed in batches without microalgae 
inoculum. Indeed, photodegradation of DCF in surface waters has been previously reported 
(Kunkel and Radke, 2012; Zhang et al., 2008) and also in HRAPs, where DCF removal was 
considerably higher during the warm/summer season (Matamoros et al., 2015). Considering 
the fate of both hydroxylated metabolites, 4-OH-DCF and 5-OH-DCF, these were almost 
completely removed in both ponds, and only 4-OH-DCF was detected in biomass from 
HRAP-test at levels < 12 ng g-1. The glucuronide metabolite of DCF was included in the 
scope of this study, but not detected in any of the influent samples. All in all, the removal 
rates observed are similar to those typically obtained in CAS or MBR treatments, due to its 
generally low biodegradability.  
Average removal rates for IBF were 79% and 78% for HRAP-control and HRAP- 
test, respectively. The removal of the metabolites was also high in both ponds, and the 
differences were not significant (p>0.05) except for cbx-IBF. Ding et al., (2017) obtained 
lower removals for IBF using the fresh-water diatom Navicula sp. under lab-controlled 
conditions (R% ranging from 20% to 60%); however, these authors worked at a much higher 
initial concentration of IBF than the environmental levels reported in the present study. 
Surprisingly, they also observed that adding Navicula sp. to the reactors decreased IBF 
degradation and extended its persistence in the water media. In a different study, IBF 
removal in the presence of microalgae was also attributed to indirect photodegradation rather 
than to sorption, due to the presence of dissolved organic matter acting as photocatalysts of 
the reaction (de Wilt et al., 2016). In fact, the concentration in the biomass of IBF in both 
HRAPs was not high (Table 3), and higher concentrations were found for its metabolites. 
The high biodegradability of IBF, which is usually efficiently eliminated during CAS 
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treatment (>90%) explains this low accumulation rate in the biomass (Ferrando-Climent et 
al., 2012). On the contrary, high removals were obtained for 1-OH IBF in both HRAPs, 
whereas it exhibited a low elimination in CAS.  
Eventually, the removal data gathered from both HRAPs was used to perform a mass 
balance estimation (Figure 5), including the concentrations found in the algal biomass. The 
biomass concentration (ng g-1) was multiplied by TSS concentration (g L-1), in order to 
homogenize the units of water and biomass concentration in the whole pond system. 
Therefore, in the present study only the elimination via adsorption or absorption to the 
microalgae biomass could be quantified. Elimination via photodegradation or 
biodegradation could not be calculated individually for each target PhAC, but we considered 
these removal pathways referencing previous research studies as explained previously in this 
section. For some of the compounds, such as the metabolites of VFX, concentrations in the 
effluent of the HRAPs were usually higher than that of the influent, and the concentration 
found in the biomass too. For instance, the concentration of N-desVFX in the HRAP-test 
effluent was more than 2 times higher than that of the influent, and 4 times higher in the 
biomass. Degradation of VFX and some of its metabolites by microalgae may lead to the 
formation of N-desVFX, explaining the high bioaccumulation observed and null removal. 
In the case of CBZ, effluent values were even 4 times higher (despite influent concentrations 
of the ponds were very low, < 50 ng L-1).  
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Figure 5. Mass balance of the evaluated pharmaceuticals and main metabolites in both HRAPs (given as % of 
the influent concentration). For each compound, the first data column corresponds to the HRAP HRAP-control and the 
second to HRAP-test.  The balance was performed with the results obtained the 4 days of biomass sampling (so some of 
the average removal values may differ from those showed in Figure 4). 
 
3.4. Biomass  
To better understand the bioaccumulation potential of the targeted compounds in the 
algal biomass, bioaccumulation factors (BAF) were calculated using equation [5]:  
𝐵𝐴𝐹 (𝐿 g-1 𝑤𝑤) =  
C biomass
Cwater
 [5] 
where Cbiomass is the concentrations found in the biomass (ng g-1 (wet weight)) and Cwater the 
concentration in the effluent wastewater of the pond. As biomass concentration was analyzed 
4 days out of the 10 days of sampling, 4 BAFs were calculated for each compound, and are 
shown in Table 4.  
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Table 4. Bioaccumulation factors (BAF) calculated for the studied compounds in the microalgal biomass (n=4). BAFs are 
expressed as L kg-1 of wet weight (ww) and dry weight (dw). Only values estimated more than two times are included.  
   HRAP-control HRAP-test 
  Compound  BAFww SD BAFdw SD BAFww SD BAFdw SD 
Antibiotics Sulfamethoxazole 144,05 9,0 1642,16 102,7 35,70 0,4 407,17 5,0 
P
sy
ch
ia
tr
ic
 d
ru
gs
 
Venlafaxine 170,7 19,3 1945,8 220,5 80,3 23,0 915,22 262,6 
N ̶ Desmethylvenlafaxine 419,63 5,0 4783,7 57,4 287,6 66,1 3279,11 753,2 
O ̶ Desmethylvenlafaxine 100,7 25,0 1147,8 285,2 52,7 8,4 600,50 96,3 
N,N-Didesmethylvenlafaxine 267,1 225,0 3044,9 2565,4 222,5 2,9 2536,76 32,9 
NO-desmethylvenlafaxine 395,6 146,9 4510,1 1674,4 142,5 13,7 1624,75 156,4 
Carbamazepine 81,3 23,9 926,3 272,9 50,1 5,7 571,21 64,8 
2 ̶ Hydroxycarbamazepine - - - - 39,8 8,6 453,26 98,3 
Acridone 914,3 192,0 10422,8 2188,7 - - - - 
A
n
al
ge
si
cs
/ 
an
ti
in
fl
am
m
at
o
ri
es
 
Diclofenac 14,4 19,0 164,2 216,4 54,9 11,0 626,01 125,4 
4-OH-Diclofenac - - - - 17,8 2.1 203,19 23.1 
Ibuprofen 5,2 7,0 59,1 79,9 10,2 4,7 116,32 54,1 
1-OH-ibuprofen 18,5 7,9 210,7 90,2 13,2 4.9 150,07 56,5 
2-OH-ibuprofen 0,3 0,4 3,7 4,3 0,08 0,01 0,96 0,1 
β-blocking 
 agents 
Metoprolol ̶ acid 30,81 10,93 351,29 124,62 41,61 15,4 474,35 175,9 
 
The highest BAF values corresponded to acridone, a photodegradation byproduct of 
CBZ, which was detected in all the biomass samples and barely in effluent wastewaters 
(values < 10 ng L-1). VFX and its metabolites also showed high BAF values, due to their low 
biodegradability in both HRAPs, as explained in section 3.4. The accumulation potential of 
this drug has been addressed in previous studies in freshwater biofilm, obtaining BAFs in 
the range of 700-3000 L kg-1(dw) in a WWTP-impacted river (Huerta et al., 2016). These 
values are higher than those obtained for microalgae, due to the chronic exposure of this 
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biofilm to the polluted river water. Santos et al., (2019) also obtained results in that range in 
river biofilm (960 L kg-1(dw)) in mesocosm-scale experiments after 72 h of exposure to an 
initial concentration of 50 µg L-1. SMX also showed a high tendency to be sorbed onto the 
biomass, with higher BAFs in microalgae than that observed in benthic invertebrates after 
lab-scale exposure experiments to 1 µg L-1 (Garcia-Galan et al., 2017). MTPA, which was 
present at higher concentrations in both HRAPs effluents than in the influent, also showed 
relatively high BAFs. Bioaccumulation potential of DCF in microalgae ranged from 164 to 
626 L kg-1(dw) and was lower than that observed in freshwater biofilm (920-3540 L kg-1), 
probably due to the shorter exposure in the HRAPs. For the rest of the compounds studied, 
and especially for the analgesics/anti-inflammatories, which are generally highly 
biodegradable, BAFs were low/negligible. BAFs were generally higher in the HRAP-control 
than in HRAP-test; despite the slightly higher biomass concentrations in HRAP-test for most 
of the compounds, the higher variability and lower removal rates in this test pond may be 
responsible of this lower BAFs. Nevertheless, the differences in the removal efficiency 
between both HRAPs were not significant. To the authors’ knowledge, there are no previous 
BAFs values of PhACs in microalgae biomass available in the literature. 
 
4. CONCLUSION 
 
 The present study has demonstrated that the implementation of HRAPs as secondary 
treatment  is a feasible alternative to CAS treatment, in terms of both overall wastewater 
treatment (COD, NH4+-N, TN, organic matter) and also of organic micropollutants removal, 
with generally higher or similar removal performances. HRAPs can be operated without 
primary treatment, without significant changes in the overall performance and saving costs. 
These ponds have shown high removal efficiencies for a wide range of PhACs, including 
many of their metabolites and transformation products. Furthermore, the removal of the 
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primary treatment that generally precedes HRAPs, seemed to have no effect in the 
performance of the ponds regarding both PhACs elimination and overall wastewater 
treatment efficiency. HRAPs configuration without a primary settler could lead to savings 
in system maintenance and costs.  However, a higher productivity of biomass in HRAP-
control than in HRAP-test was observed during the sampling campaign, with values up to 3 
times higher (14.6 gVSS m-²·d-1 vs 5 gVSS m-²·d-1), due to the light blockage in HRAP-test 
that reduced biomass growth.  One of the main advantages of using microalgae in wastewater 
treatment is indeed that the biomass produced can be harvested to obtain biofertilizers  (as it 
recycles nutrients such as nitrogen or phosphorus), bioenergy and other added-value 
products etc, so a higher biomass production is very convenient.  
 The removal of the target PhACs and the corresponding metabolites in both HRAPs 
has usually ranged from moderate to high. For some recalcitrant compounds such as CBZ or 
MTP and its metabolite, MTPA, removal efficiencies did not improved from those obtained 
in CAS treatment. On the contrary, for some compounds such as VFX, O-desVFX or MTZ, 
which are barely removed during CAS treatments, removals were higher, resulting in values 
of 50%, 35% and 100% in average, respectively. Moderate removals, such as those of DCF 
or SMX, can be explained in terms of back-transformation in the parent drug of their 
corresponding acetylated or glucuronidated metabolites. On the contrary, for some 
compounds such as VFX, O-desVFX or MTZ, which are barely removed during CAS 
treatments, removals were higher, resulting in values of 50%, 35% and 100% in average, 
respectively. Occurrence of the target analytes in microalgae biomass has also been 
evaluated, in order to discern if sorption had been the main removal mechanism during 
treatment. In the case of VFX and O-desVFX, bioadsorption/bioaccumulation in the 
microalgae biomass may have played a decisive role in their elimination. As expected, the 
less biodegradable compounds showed the highest tendencies to be adsorbed onto the 
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biomass (highest BAFs). To the author’s knowledge, this is the first time that BAF values 
are estimated for microalgae biomass.  
 All in all, data on PhACs removal in HRAPs under real conditions (environmental 
concentrations) is still scarce, as most of the studies carried out are lab-scaled, with pure 
cultures, sterile conditions and at much higher doped concentrations of the contaminant. To 
the author’s knowledge, this is the first study dealing with the occurrence of PhACs and 
metabolites in microalgae biomass under environmental conditions. 
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